lobbying_activities: 2102456
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2102456 | 61092960-daf3-44d9-bde5-2014f1608bed | Q1 | JEFFREY J. KIMBELL & ASSOCIATES, INC. | 46038 | HORIZON THERAPEUTICS USA, INC. (FKA HORIZON PHARMA USA, INC.) | 2018 | first_quarter | HCR | 340B drug pricing program; policies and regulations impacting drugs for rare diseases and conditions | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2018-04-06T12:54:46.120000-04:00 |